b.well Health Unveils White-Label AI Assistant 'bailey'
b.well Connected Health has announced the launch of bailey™, a ready-to-deploy, white-label AI health assistant. The product allows healthcare organizations to integrate a branded AI assistant into their own applications within weeks. The assistant is powered by b.well's patient data platform, which aims to solve healthcare data fragmentation.
- The AI assistant "bailey" is named after the daughter of b.well's founder and CEO, Kristen Valdes. Valdes's personal experience navigating the healthcare system for her daughter, who has a significant autoimmune disorder, was the inspiration for the company. - It took seven years, numerous misdiagnoses, and a life-threatening complication from a medication for Valdes's daughter to receive an appropriate diagnosis, which Valdes herself pinpointed by aggregating and analyzing her daughter's siloed health data. - Prior to founding b.well in 2015, Kristen Valdes was a Vice President at United Healthcare, where she ran Medicare Advantage plans. - In February 2024, b.well Connected Health announced a $40 million Series C funding round led by Leavitt Equity Partners, bringing its total funding to over $96 million. - As part of the latest funding round, the Head of Digital Health at Samsung, Hon Pak, joined b.well's board of directors, following an integration partnership with the company. - The problem of healthcare data fragmentation is a well-documented issue where patient information is scattered across multiple, non-communicating systems, which can lead to incomplete data, medical errors, and redundant tests. - The global market for AI in patient engagement was valued at approximately $6.08 billion in 2023 and is projected to grow to over $23 billion by 2030. - b.well's platform utilizes Fast Healthcare Interoperability Resources (FHIR), a standard for exchanging healthcare information electronically, to unify data from various sources like providers, payers, and wearables.
